Variant report

Variant	esv1804261
Chromosome Location	chr2:234646637-234659502
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:234653876-234654428	HepG2	liver:	n/a	n/a
2	ATF3	chr2:234653988-234654486	A549	lung:	n/a	n/a
3	BCL3	chr2:234653958-234654499	A549	lung:	n/a	n/a
4	BCL3	chr2:234653885-234654544	A549	lung:	n/a	n/a
5	BHLHE40	chr2:234654058-234654451	HepG2	liver:	n/a	n/a
6	CBX3	chr2:234659353-234659614	K562	blood:	n/a	n/a
7	CEBPB	chr2:234653961-234654410	HepG2	liver:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
8	CEBPB	chr2:234657008-234657264	IMR90	lung:	n/a	chr2:234657082-234657093 chr2:234657082-234657093 chr2:234657104-234657115
9	CEBPB	chr2:234653979-234654335	HepG2	liver:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
10	CEBPB	chr2:234656935-234657273	A549	lung:	n/a	chr2:234657082-234657093 chr2:234657082-234657093 chr2:234657104-234657115
11	CEBPB	chr2:234654020-234654389	A549	lung:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
12	CEBPB	chr2:234656934-234657289	HepG2	liver:	n/a	chr2:234657082-234657093 chr2:234657082-234657093 chr2:234657104-234657115
13	CEBPB	chr2:234653908-234654385	HepG2	liver:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
14	CEBPB	chr2:234653892-234654497	A549	lung:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
15	CEBPB	chr2:234653902-234654598	HepG2	liver:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
16	CEBPB	chr2:234653943-234654318	A549	lung:	n/a	chr2:234654071-234654082 chr2:234654069-234654086 chr2:234654118-234654130
17	CEBPD	chr2:234654049-234654478	HepG2	liver:	n/a	n/a
18	CHD2	chr2:234654164-234654273	HepG2	liver:	n/a	n/a
19	CREB1	chr2:234654062-234654459	A549	lung:	n/a	n/a
20	CREB1	chr2:234653968-234654547	HepG2	liver:	n/a	n/a
21	CREB1	chr2:234653888-234654608	HepG2	liver:	n/a	n/a
22	CREB1	chr2:234654194-234654509	A549	lung:	n/a	n/a
23	CTCF	chr2:234651956-234652041	Kidney_OC	kidney:	n/a	n/a
24	CTCF	chr2:234651938-234652009	GM20000	blood:	n/a	n/a
25	EP300	chr2:234653810-234654542	A549	lung:	n/a	chr2:234654068-234654082 chr2:234653862-234653871
26	EP300	chr2:234653933-234654548	HepG2	liver:	n/a	chr2:234654068-234654082
27	EP300	chr2:234654030-234654453	HepG2	liver:	n/a	chr2:234654068-234654082
28	EP300	chr2:234653700-234654700	A549	lung:	n/a	chr2:234654068-234654082 chr2:234653862-234653871
29	EP300	chr2:234647009-234647365	HepG2	liver:	n/a	n/a
30	EP300	chr2:234653868-234654574	HepG2	liver:	n/a	chr2:234654068-234654082
31	FOSL2	chr2:234654000-234654628	HepG2	liver:	n/a	n/a
32	FOSL2	chr2:234654004-234654404	A549	lung:	n/a	n/a
33	FOSL2	chr2:234653946-234654485	HepG2	liver:	n/a	n/a
34	FOSL2	chr2:234653860-234654613	A549	lung:	n/a	n/a
35	FOXA1	chr2:234653830-234654570	HepG2	liver:	n/a	n/a
36	FOXA1	chr2:234653527-234654585	HepG2	liver:	n/a	n/a
37	FOXA1	chr2:234653906-234654589	HepG2	liver:	n/a	n/a
38	FOXA1	chr2:234653871-234654608	HepG2	liver:	n/a	n/a
39	FOXA2	chr2:234653649-234654629	A549	lung:	n/a	n/a
40	FOXA2	chr2:234653884-234654483	HepG2	liver:	n/a	n/a
41	FOXA2	chr2:234653954-234654644	A549	lung:	n/a	n/a
42	FOXA2	chr2:234653696-234654749	HepG2	liver:	n/a	n/a
43	GATA3	chr2:234653893-234654633	A549	lung:	n/a	n/a
44	GATA3	chr2:234653885-234654644	A549	lung:	n/a	n/a
45	HDAC2	chr2:234653853-234654551	HepG2	liver:	n/a	n/a
46	HDAC2	chr2:234653902-234654531	HepG2	liver:	n/a	n/a
47	HEY1	chr2:234652495-234652743	K562	blood:	n/a	n/a
48	HNF4A	chr2:234647102-234647414	HepG2	liver:	n/a	chr2:234647219-234647234
49	HNF4A	chr2:234654029-234654486	HepG2	liver:	n/a	chr2:234654285-234654298 chr2:234654285-234654300 chr2:234654281-234654303 chr2:234654233-234654248 chr2:234654285-234654298
50	HNF4A	chr2:234653907-234654493	HepG2	liver:	n/a	chr2:234654285-234654298 chr2:234654285-234654300 chr2:234654281-234654303 chr2:234654233-234654248 chr2:234654285-234654298

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:234653891-234653941	AoSMC	blood vessel:	n/a
2	chr2:234653891-234653941	AoSMC	blood vessel:	n/a
3	chr2:234653891-234653941	PANC-1	pancreas:	n/a
4	chr2:234652466-234652516	SK-N-SH	brain:	n/a
5	chr2:234652363-234652413	HRPEpiC	eye:	n/a
6	chr2:234652669-234652719	AG09309	skin:	n/a
7	chr2:234651850-234651900	AG09309	skin:	n/a
8	chr2:234650765-234650815	Jurkat	blood:	n/a
9	chr2:234652669-234652719	BJ	skin:	n/a
10	chr2:234649204-234649254	NHBE	bronchial:	n/a
11	chr2:234653891-234653941	CMK	blood:	n/a
12	chr2:234652681-234652731	RPTEC	kidney:	n/a
13	chr2:234652601-234652651	MCF-7	breast:	n/a
14	chr2:234652669-234652719	HCPEpiC	choroid plexus:	n/a
15	chr2:234650765-234650815	NB4	blood:	n/a
16	chr2:234652466-234652516	HUVEC	blood vessel:	n/a
17	chr2:234652363-234652413	GM12878	blood:	n/a
18	chr2:234652681-234652731	AG04450	lung:	fetal
19	chr2:234652363-234652413	MCF-7	breast:	n/a
20	chr2:234649204-234649254	AG10803	skin:	n/a
21	chr2:234651850-234651900	AG04450	lung:	fetal
22	chr2:234652363-234652413	BJ	skin:	n/a
23	chr2:234652601-234652651	Caco-2	colon:	n/a
24	chr2:234652466-234652516	HAEpiC	amniotic membrane:	n/a
25	chr2:234652681-234652731	SK-N-SH	brain:	n/a
26	chr2:234655709-234655759	K562	blood:	n/a
27	chr2:234651850-234651900	HIPEpiC	eye:	n/a
28	chr2:234655709-234655759	HAEpiC	amniotic membrane:	n/a
29	chr2:234652363-234652413	HIPEpiC	eye:	n/a
30	chr2:234651850-234651900	Jurkat	blood:	n/a
31	chr2:234652601-234652651	PrEC	prostate:	n/a
32	chr2:234653891-234653941	SKMC	muscle:	n/a
33	chr2:234649204-234649254	Hepatocyte	liver:	n/a
34	chr2:234652601-234652651	PANC-1	pancreas:	n/a
35	chr2:234652681-234652731	ECC-1	luminal epithelium:	n/a
36	chr2:234650765-234650815	HMEC	breast:	n/a
37	chr2:234652466-234652516	IMR90	lung:	fetal
38	chr2:234655709-234655759	GM12891	blood:	n/a
39	chr2:234652363-234652413	Caco-2	colon:	n/a
40	chr2:234652363-234652413	ProgFib	skin:	n/a
41	chr2:234652601-234652651	ECC-1	luminal epithelium:	n/a
42	chr2:234652601-234652651	SK-N-MC	brain:	n/a
43	chr2:234651850-234651900	ovcar-3	ovarian:	n/a
44	chr2:234652681-234652731	HNPCEpiC	eye:	n/a
45	chr2:234650765-234650815	HUVEC	blood vessel:	n/a
46	chr2:234652363-234652413	AG10803	skin:	n/a
47	chr2:234652669-234652719	AG04449	skin:	fetal
48	chr2:234651850-234651900	HMEC	breast:	n/a
49	chr2:234651850-234651900	AG09319	gingival:	n/a
50	chr2:234650765-234650815	GM06990	blood:	n/a

No.	Distal block	Cell Line	Cell type
1	chr17:63274126..63274957-chr2:234657055..234657979,2	MCF-7	breast:
2	2:234543708-234558325..2:234649753-234657866	Hela-S3	cervix:
3	chr2:234650134..234652973-chr2:234653062..234655371,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-UGT1A1-1	chr2:234659263-234659366	NONHSAT077510
2	lnc-UGT1A1-2	chr2:234649334-234649521	NONHSAT077507
3	lnc-UGT1A1-2	chr2:234647598-234647701	NONHSAT077507
4	lnc-UGT1A1-2	chr2:234650166-234650603	NONHSAT077507

Variant related genes	Relation type
UGT1A2P	TF binding region
ENSG00000248705	TF binding region
ENSG00000248114	TF binding region
DNAJB3	TF binding region
UGT1A2P	CpG island
ENSG00000248705	CpG island
ENSG00000248114	CpG island
DNAJB3	CpG island
ENSG00000234143	chromatin interactions
ENSG00000242515	chromatin interactions
ENSG00000227802	chromatin interactions

Extended variants
information (count: 651 )
Associated
traits (count: 64 )

Variant overlapped rSNPs/rCNVs (count:651 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs11902620	chr2:234646637-234646638	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs11902624	chr2:234646664-234646665	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs28899194	chr2:234646682-234646683	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs542059461	chr2:234646683-234646684	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs17862873	chr2:234646722-234646723	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs527833825	chr2:234646726-234646727	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs546300449	chr2:234646775-234646776	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs577754213	chr2:234646825-234646826	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs566528784	chr2:234646826-234646827	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs543563413	chr2:234646834-234646835	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs563579368	chr2:234646836-234646837	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs536220321	chr2:234646875-234646876	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs56839564	chr2:234646876-234646877	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs190187890	chr2:234646881-234646882	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs57963849	chr2:234646889-234646890	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs569089300	chr2:234646910-234646911	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs181527860	chr2:234646952-234646953	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs187057968	chr2:234646990-234646991	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs568263428	chr2:234647053-234647054	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs529176088	chr2:234647107-234647108	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs113157638	chr2:234647137-234647138	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs533932753	chr2:234647155-234647156	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs553988769	chr2:234647170-234647171	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs577240283	chr2:234647195-234647196	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs200356617	chr2:234647207-234647208	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs545904932	chr2:234647242-234647243	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs190192640	chr2:234647261-234647262	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs182421853	chr2:234647288-234647289	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs542122703	chr2:234647301-234647302	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs562004619	chr2:234647305-234647306	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs377285735	chr2:234647316-234647317	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs6722076	chr2:234647317-234647318	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs35967186	chr2:234647353-234647354	Weak transcription Enhancers Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs560020824	chr2:234647445-234647446	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
35	rs532221279	chr2:234647450-234647451	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
36	rs149365680	chr2:234647455-234647456	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
37	rs6431628	chr2:234647478-234647479	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
38	rs551176357	chr2:234647487-234647488	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
39	rs548510630	chr2:234647596-234647597	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
40	rs185032908	chr2:234647612-234647613	Weak transcription Enhancers Bivalent Enhancer	lncRNA	n/a	Overlapped CNVs	n/a
41	rs189887641	chr2:234647710-234647711	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
42	rs368529086	chr2:234647756-234647757	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
43	rs547420418	chr2:234647759-234647760	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs570890692	chr2:234647779-234647780	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs539919985	chr2:234647785-234647786	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs182453819	chr2:234647801-234647802	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs76713617	chr2:234647806-234647807	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs535426157	chr2:234647843-234647844	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs555664061	chr2:234647844-234647845	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs185605986	chr2:234647854-234647855	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:64)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Ependymoma	16718352	CNVD
Melanoma	18172304	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	17603634	CNVD
Breast cancer	16272173	CNVD
Ewing''s sarcoma	17952124	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Autism	16446308	CNVD
Autism	19401682	CNVD
Colorectal cancer	16272173	CNVD
Lung cancer	18438408	CNVD
Acute myeloid leukemia	20729466	CNVD
small cell lung cancer	20016488	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Urothelial carcinoma	21177765	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cervical cancer	21062161	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Chordoma	18071362	CNVD
Developmental delay	21147756	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Cancer	22429812	CNVD
Bladder cancer	21909424	CNVD
Renal cell carcinoma	21668985	CNVD
Breast cancer	21785460	CNVD
Prostate cancer	18632612	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
prenatal diagnosis	22389664	CNVD
Myelofibrosis	22110671	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Mental retardation	20152051	CNVD
Cancer	21183584	CNVD
Albright''s disease	22277900	CNVD
Brachydactyly-Mental Retardation Syndrome	22470819	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Colorectal cancer	19359472	CNVD
Autism	18414403	CNVD
Chronic myeloid leukemia	21384125	CNVD
Pancreatic cancer	17952125	CNVD
Congenital anomalies of the kidney and urinary tract	20605837	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:63 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:234620400-234659200	Weak transcription	Colonic Mucosa	Colon
2	chr2:234620600-234652200	Weak transcription	Esophagus	oesophagus
3	chr2:234626200-234649600	Weak transcription	Rectal Mucosa Donor 29	rectum
4	chr2:234626600-234668400	Weak transcription	NHEK	skin
5	chr2:234634600-234648400	Weak transcription	A549	lung
6	chr2:234645400-234648600	Enhancers	Liver	Liver
7	chr2:234645600-234647000	Enhancers	Duodenum Mucosa	Duodenum
8	chr2:234646200-234648000	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
9	chr2:234646400-234648800	Bivalent Enhancer	HepG2	liver
10	chr2:234646400-234651000	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
11	chr2:234646400-234666600	Weak transcription	Stomach Mucosa	stomach
12	chr2:234647000-234648000	Weak transcription	Duodenum Mucosa	Duodenum
13	chr2:234647000-234648400	Enhancers	Fetal Intestine Large	intestine
14	chr2:234647600-234647800	Enhancers	Gastric	stomach
15	chr2:234647800-234652200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
16	chr2:234647800-234655000	Weak transcription	Gastric	stomach
17	chr2:234648000-234648600	Enhancers	Duodenum Mucosa	Duodenum
18	chr2:234648000-234649800	Strong transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
19	chr2:234648400-234648600	Enhancers	A549	lung
20	chr2:234648600-234649200	Weak transcription	Duodenum Mucosa	Duodenum
21	chr2:234648600-234649200	Weak transcription	A549	lung
22	chr2:234648600-234650400	Weak transcription	Liver	Liver
23	chr2:234649600-234649800	Enhancers	Rectal Mucosa Donor 29	rectum
24	chr2:234649800-234652200	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
25	chr2:234649800-234658800	Weak transcription	Rectal Mucosa Donor 29	rectum
26	chr2:234650400-234652600	Genic enhancers	Liver	Liver
27	chr2:234651000-234652800	Strong transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
28	chr2:234652200-234652600	ZNF genes & repeats	iPS DF 6.9 Cell Line	embryonic stem cell
29	chr2:234652200-234652600	ZNF genes & repeats	iPS DF 19.11 Cell Line	embryonic stem cell
30	chr2:234652200-234652600	ZNF genes & repeats	Esophagus	oesophagus
31	chr2:234652200-234652800	Strong transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
32	chr2:234652400-234652600	Flanking Active TSS	H1 Derived Mesenchymal Stem Cells	ES cell derived
33	chr2:234652600-234654400	Enhancers	Liver	Liver
34	chr2:234652600-234654600	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
35	chr2:234652800-234658200	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
36	chr2:234652800-234659200	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
37	chr2:234653200-234654400	Enhancers	HepG2	liver
38	chr2:234653200-234655600	Enhancers	Fetal Intestine Small	intestine
39	chr2:234653400-234653800	Enhancers	A549	lung
40	chr2:234653800-234654200	Active TSS	A549	lung
41	chr2:234654200-234654800	Enhancers	Small Intestine	intestine
42	chr2:234654200-234655000	Enhancers	A549	lung
43	chr2:234654200-234655400	Enhancers	Duodenum Mucosa	Duodenum
44	chr2:234654200-234655400	Enhancers	Fetal Intestine Large	intestine
45	chr2:234654400-234654600	Flanking Active TSS	HepG2	liver
46	chr2:234654400-234656000	Flanking Active TSS	Liver	Liver
47	chr2:234654600-234655800	Bivalent Enhancer	HepG2	liver
48	chr2:234655000-234655200	Flanking Active TSS	A549	lung
49	chr2:234655000-234655600	Enhancers	Gastric	stomach
50	chr2:234655200-234655400	Enhancers	A549	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links